Latest News about BMY
Recent news which mentions BMY
From Benzinga
From Motley Fool
Bristol Myers' Expanded Approval For Anemia Drug, Shows Superior Efficacy Over Concurrent Blood Transfusion
August 29, 2023
Tickers
BMY
From Benzinga
From MarketWatch
Important Data Ahead, Tesla Turning On Massive Nvidia Cluster, 10 Drugs Name For Price Cuts
August 29, 2023
From Benzinga
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
August 28, 2023
From Benzinga
A Step Closer To Cheaper Drugs For Americans: Price Negotiation And Its Implications
August 28, 2023
From Benzinga
Is Alexandria Real Estate Equities a Buy?
August 26, 2023
From Motley Fool
Pharma Giants Unite Against Drug Price Negotiation: AstraZeneca Latest To Challenge The Government
August 25, 2023
From Benzinga
As Medicare picks 10 drugs for price negotiations, 50 million people stand to benefit — even if their drugs aren’t on the list
August 25, 2023
From MarketWatch
From Benzinga
From InvestorPlace
3 Sorry Pharma Stocks to Sell in August Before It’s Too Late
August 22, 2023
From InvestorPlace
Bristol-Myers Squibb Unusual Options Activity For August 21
August 21, 2023
Tickers
BMY
From Benzinga
2 Dividend Stocks to Buy Hand Over Fist
August 16, 2023
From Motley Fool
2 Blue Chip Dividend Stocks That Are Top Buys in August
August 14, 2023
From Motley Fool
UnitedHealth Group, Pioneer Natural Resources And A Credit Card Giant: CNBC's 'Final Trades'
August 14, 2023
From Benzinga
From Benzinga
From InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
July 31, 2023
From Benzinga
From InvestorPlace
Johnson & Johnson, Other Pharma Makers Anticipate Reformulated Injectable Drugs May Exclude Price Negotiations
July 28, 2023
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.